Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis.

Cancers (Basel) · 2021 · PMC8750103 · PMID 35008346

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although no superior effects were indicated between ICIs, patients who received nivolumab showed a trend toward improvement in terms of OS compared with those who received pembrolizumab and tremelimumab (HR: 0.81, 95% CI: 0.43–1.54 for pembrolizumab; HR: 0.78, 95% CI: 0.56–1.09 for tremelimumab).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.